LUNA

Health Care Sector Update for 03/13/2024: LUNA, HRTX, UNH, JNJ, BMY

Health care stocks were lower late Wednesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each sliding around 0.5%.

The iShares Biotechnology ETF (IBB) eased 0.1%.

In corporate news, Luna Innovations (LUNA) shares plunged almost 37% after the company said late Tuesday it will delay the release of its Q4 results.

Heron Therapeutics (HRTX) shares were soaring 26%, a day after the company reported better-than-expected Q4 results.

UnitedHealth (UNH) is under investigation from the US Department of Health & Human Services following a cyberattack on its Change Healthcare unit in late February, according to a statement Wednesday from the agency's Office for Civil Rights. UnitedHealth shares fell 0.3%.

The US Food and Drug Administration's staff on Wednesday raised concerns about whether the cancer cell therapies of Johnson & Johnson (JNJ) and Bristol Myers Squibb (BMY) would benefit adult patients with myeloma, a type of blood cancer, due to higher rate of early deaths in their respective late-stage trials, according to briefing documents. Johnson & Johnson shares were down 1.1% and Bristol Myers Squibb was shedding 3.3%.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.